<SEC-DOCUMENT>0000905148-21-000683-index.html : 20211022
<SEC-HEADER>0000905148-21-000683.hdr.sgml : 20211022
<ACCEPTANCE-DATETIME>20211021185221
ACCESSION NUMBER:		0000905148-21-000683
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20211022
DATE AS OF CHANGE:		20211021

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pyxis Oncology, Inc.
		CENTRAL INDEX KEY:			0001782223
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831160910
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92951
		FILM NUMBER:		211338225

	BUSINESS ADDRESS:	
		STREET 1:		800 BOYLSTON STREET
		STREET 2:		SUITE 1555
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02199
		BUSINESS PHONE:		(617) 351-2575

	MAIL ADDRESS:	
		STREET 1:		800 BOYLSTON STREET
		STREET 2:		SUITE 1555
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02199

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sullivan Lara
		CENTRAL INDEX KEY:			0001769457

	FILING VALUES:
		FORM TYPE:		SC 13D

	MAIL ADDRESS:	
		STREET 1:		C/O REXAHN PHARMACEUTICALS, INC.
		STREET 2:		15245 SHADY GROVE ROAD, SUITE 455
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>efc21-572_sc13d.htm
<TEXT>
Document 1 - file: efc21-572_sc13d.htm

</DOCUMENT>
</SEC-DOCUMENT>